Asian Phytoceuticals PCL
SET:APCO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its 3-Year Average (32.4), the stock would be worth ฿3.62 (34% upside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 24.2 | ฿2.7 |
0%
|
| 3-Year Average | 32.4 | ฿3.62 |
+34%
|
| 5-Year Average | 30.4 | ฿3.4 |
+26%
|
| Industry Average | 15.5 | ฿1.73 |
-36%
|
| Country Average | 8.5 | ฿0.95 |
-65%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| TH |
A
|
Asian Phytoceuticals PCL
SET:APCO
|
1.6B THB | 24.2 | 29.2 | |
| FR |
|
L'Oreal SA
PAR:OR
|
184.2B EUR | 21.2 | 30.1 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
92B GBP | 12.1 | 11.2 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.2T INR | 46.4 | 37.4 | |
| UK |
|
HALEON PLC
LSE:HLN
|
31.4B GBP | 14.4 | 18.8 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
27.4B USD | 19 | -154.1 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
16.4B EUR | 17.7 | 17.4 | |
| JP |
|
Kao Corp
TSE:4452
|
2.7T JPY | 12.8 | 22.6 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.1T INR | 48.8 | 63.1 | |
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD | 552.9 | -4 624.4 | |
| IN |
|
Dabur India Ltd
NSE:DABUR
|
783.4B INR | 40.4 | 43.5 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 6.1 |
| Median | 8.5 |
| 70th Percentile | 12 |
| Max | 13 428 |
Other Multiples
Asian Phytoceuticals PCL
Glance View
Asian Phytoceuticals Public Co., Ltd. engages in the research and development, manufacture, and distribution of health and beauty products from natural extracts. The company is headquartered in Lamphun, Lamphun. The company went IPO on 2011-11-04. The firm specializes in the manufacture of dietary supplements, cosmetics and personal care products developed from natural plant and botanical extracts. The firm offers products across various categories, including anti-wrinkle products, slimming products, and other health products. The Company’s slimming products are sold under Gold Shape brand. The firm's anti-wrinkle and anti-spots products are sold under brands, including Gold Figor, Garcinia and Asian Life. The Company, through its subsidiary, Killer T Cell for Pets Co., Ltd., is engaged in the business of distribution and marketing of pharmaceutical food supplements in the global animal market.
